The economics of cash-pay medicine are straightforward in principle and rare in practice. You pay a known amount for a defined service, at the time of that service, with no intermediary deciding after the fact what it was worth. No facility fees appended at checkout. No explanation-of-benefits letter arriving weeks later from an entity you've never encountered. No rate inflation built into a number that insurance will "discount" back to something reasonable. What's listed here is what you pay.
That transparency extends to what we offer. FDA-cleared treatments are identified as such. Biologics that exist in a legitimate but less-regulated space are discussed openly, with the evidence on the table. Pricing for procedures that genuinely depend on clinical variables — complexity, tissue involved, protocol length — is handled in a direct conversation rather than a hidden form. If something isn't listed, it's because the right number requires knowing your situation first, not because we're trying to make you call.
For patients carrying insurance who are also pursuing surgical care: we provide a detailed superbill at every visit, which you can submit to your carrier for potential reimbursement. We make no guarantees about what your plan will cover — insurance reimbursement for cash-pay visits varies widely — but we'll give you everything you need to make the case.
Visits here run longer than you're used to. That's intentional. A meaningful clinical conversation about musculoskeletal health, performance optimization, or a regenerative medicine protocol can't happen in fifteen minutes. The pricing below reflects that — not a premium for premium's sake, but an honest accounting of what real care takes.
An unhurried, comprehensive visit built around where you are and where you want to be. Not a rushed new-patient slot — a real starting point.
Platelet-rich plasma prepared and delivered at the time of your visit. Pricing covers a single joint or area.
For patients with a defined, acute-to-subacute problem who want focused clinical attention and a biologic intervention without committing to a longer program. A clear entry point with real deliverables.
Where root cause work begins in earnest. For patients ready to take musculoskeletal health seriously and willing to give the process enough time to produce meaningful data.
The full longitudinal relationship. For patients who understand that musculoskeletal longevity is a long game — and want a physician tracking the arc alongside them.
BMAC, exosome therapy, surgical biologic augmentation, peptide protocols, post-operative concierge arrangements, and multi-modal programs are priced based on clinical specifics. If your situation doesn't fit neatly into the options above — or you're not sure where to start — reach out directly. You'll get a straightforward answer and a real conversation, not a sales funnel.
© 2026 All Rights Reserved | Regen ATX
Website Designed & Managed by BJC Media